Efficacy and Safety of Cilostazol in Patients of Vascular Cognitive Impairment-no Dementia (VCIND)
Status:
Unknown status
Trial end date:
2015-11-01
Target enrollment:
Participant gender:
Summary
Patients of vascular cognitive impairment-no dementia (VCIND) in one group is prescribed
cilostazol,in the other group is prescribed aspirin. Evaluate both of them in cognitive
function, MRI and other sides at given time. The investigators hypothesize that cilostazol is
more efficient and safer than aspirin in patients with VCIND.